HOOKIPA Pharma Inc (HOOK)
0.7204
0.00 (0.00%)
USD |
NASDAQ |
Mar 27, 16:00
0.7146
-0.01
(-0.81%)
After-Hours: 20:00
HOOKIPA Pharma Profit Margin (Quarterly): -335.1% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -335.1% |
September 30, 2023 | -277.6% |
June 30, 2023 | -672.5% |
March 31, 2023 | -619.6% |
December 31, 2022 | -157.3% |
September 30, 2022 | -819.7% |
June 30, 2022 | -595.6% |
March 31, 2022 | -1.24K% |
December 31, 2021 | -545.2% |
September 30, 2021 | -517.3% |
June 30, 2021 | -318.9% |
March 31, 2021 | -325.2% |
Date | Value |
---|---|
December 31, 2020 | -241.6% |
September 30, 2020 | -336.4% |
June 30, 2020 | -106.1% |
March 31, 2020 | -295.6% |
December 31, 2019 | -283.1% |
September 30, 2019 | -558.6% |
June 30, 2019 | -298.2% |
March 31, 2019 | -417.4% |
December 31, 2018 | -37.24% |
September 30, 2018 | -208.1% |
June 30, 2018 | -896.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.24K%
Minimum
Mar 2022
-106.1%
Maximum
Jun 2020
-448.2%
Average
-335.7%
Median
Profit Margin (Quarterly) Benchmarks
Gilead Sciences Inc | 20.09% |
Absci Corp | -6.97K% |
NovaBay Pharmaceuticals Inc | -53.81% |
Palatin Technologies Inc | -385.6% |
iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -84.41% |
Return on Assets | -47.99% |
Return on Invested Capital | -83.08% |
Operating Margin (Quarterly) | -194.7% |
Return on Net Operating Assets | -199.3% |